Is a daily dose of 7.5 mg methotrexate appropriate, or should methotrexate be administered weekly?

Critical Medication Error: Methotrexate Must Be Dosed Weekly, Not Daily

A daily dose of 7.5 mg methotrexate is INCORRECT and potentially life-threatening—methotrexate for rheumatoid arthritis and psoriasis must be administered as a WEEKLY dose, not daily. This represents a common and dangerous dosing error that has resulted in fatal toxicity. 1, 2, 3

Immediate Action Required

• STOP the current daily dosing regimen immediately 2
• The patient is currently receiving 52.5 mg per week (7.5 mg × 7 days), which is more than double the maximum recommended weekly dose 1, 4
• This places the patient at extreme risk for:
  • Severe myelosuppression and pancytopenia 1
  • Hepatotoxicity 1
  • Gastrointestinal toxicity 1
  • Death 1, 2

Correct Dosing Regimen

Methotrexate should be administered as a single weekly dose (or divided into 3 doses over 24 hours once per week). 1

For Rheumatoid Arthritis:

• Starting dose: 10–15 mg once weekly (oral) 1, 4, 5
• Target dose: Titrate to ≥15 mg/week within 4–6 weeks, up to 20–30 mg/week maximum based on response and tolerability 1, 4
• The 2021 American College of Rheumatology conditionally recommends reaching at least 15 mg weekly within 4–6 weeks to optimize efficacy 1, 4

For Psoriasis:

• Typical range: 7.5–25 mg once weekly 1, 4
• May be given as a single dose or divided into 3 doses over 24 hours (once per week) 1
• NICE guidelines suggest starting at 5–10 mg/week with gradual increases up to 25 mg/week maximum 4

Why Daily Dosing Is Dangerous

Daily dosing of methotrexate has been definitively shown to be both less effective and more toxic than weekly dosing. 1, 6

• A randomized controlled trial demonstrated that daily dosing (2.5 mg daily for 6 days/week) showed less clinical benefit than weekly dosing (15 mg divided over 24 hours weekly) 1
• Daily dosing was more likely to cause liver enzyme elevation 1, 6
• The FDA drug label explicitly states: "To reduce the incidence of major toxic effects, methotrexate should never be given in daily doses" 3
• Mistaken daily use of the recommended weekly dose has led to fatal toxicity 1, 2

Essential Safety Measures

Folate Supplementation:

• Prescribe folic acid ≥5 mg per week (or 1–5 mg daily) 1, 4, 5
• Give on days other than the methotrexate dose day to avoid reducing efficacy 1, 4
• This reduces hepatic abnormalities, gastrointestinal side effects, and possibly hematologic toxicity 1, 5

Urgent Monitoring (Given Current Overdosing):

• Immediate complete blood count (CBC) with differential and platelets to assess for myelosuppression 1, 2
• Liver function tests (AST, ALT, alkaline phosphatase, albumin) 1, 2
• Serum creatinine and BUN to assess renal function 1, 2
• If significant myelosuppression is detected, administer leucovorin (folinic acid) 10 mg/m² immediately, with subsequent doses every 6 hours 1

Ongoing Monitoring (Once Corrected to Weekly Dosing):

• CBC, liver enzymes, and creatinine: Every 1–2 months initially, then every 1–3 months once stable 1, 2
• For psoriasis, monitoring can be spaced to every 3–6 months once dose is stable 4

Common Pitfalls to Avoid

The most critical error is prescribing or taking methotrexate daily instead of weekly. 1, 2, 3

• Both prescribers and pharmacists must emphasize to patients that the dose is weekly, not daily 1, 2
• Prescriptions should not be written on a PRN basis 2
• Written instructions must clearly state "ONCE WEEKLY" 1, 2
• Major risk factors for toxicity include: dosing errors, renal impairment, advanced age, lack of folate supplementation, drug interactions (especially NSAIDs, trimethoprim, sulfonamides), and hypoalbuminemia 1, 2

Drug Interactions Requiring Caution

NSAIDs, salicylates, trimethoprim, and sulfonamides can increase methotrexate toxicity by reducing renal tubular secretion. 1, 2, 3

• These are commonly co-prescribed in rheumatoid arthritis and psoriasis patients 2, 3
• While concurrent use is common in RA at standard weekly doses (7.5–15 mg/week), higher doses increase risk 2
• Probenecid also reduces renal clearance and should be used with careful monitoring 2